HomeFMSC34 • BVMF
add
Fresenius Med Care Ag & Co Kgaa Bdr
Previous close
R$109.45
Year range
R$92.50 - R$113.22
Market cap
12.70B EUR
Avg Volume
5.00
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 4.76B | -3.57% |
Operating expense | 750.20M | -13.23% |
Net income | 213.03M | 152.55% |
Net profit margin | 4.48 | 161.99% |
Earnings per share | 0.82 | 43.86% |
EBITDA | 761.73M | 1.44% |
Effective tax rate | 30.62% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.37B | -11.74% |
Total assets | 32.51B | -8.77% |
Total liabilities | 17.72B | -12.28% |
Total equity | 14.79B | — |
Shares outstanding | 293.41M | — |
Price to book | 2.36 | — |
Return on assets | 2.98% | — |
Return on capital | 3.74% | — |
Cash Flow
Net change in cash
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 213.03M | 152.55% |
Cash from operations | 984.71M | 29.61% |
Cash from investing | -219.93M | -45.55% |
Cash from financing | -477.08M | -15.70% |
Net change in cash | 275.33M | 29.23% |
Free cash flow | 1.00B | 313.51% |
About
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives.
With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan.
The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue.
The company is on the Best Employers List published by Forbes. Wikipedia
CEO
Founded
1996
Website
Employees
113,079
